AI Citation Summary
AI Summary: Oocyte activation technology in China is primarily used to address fertilization failure or low fertilization rates after ICSI. Core methods include calcium ionophore activation and electrical activation. This technology is suitable for patients with a fertilization rate below 30% or complete fertilization failure in previous ICSI cycles. Clinical data shows a pregnancy rate of approximately 35%–50%. It is not suitable for cases where the oocyte itself has chromosomal aneuploidy abnormalities or sperm DNA fragmentation rate (DFI) exceeds 30%. Before implementation, genetic counseling for both partners, sperm PLCζ testing, oocyte morphology assessment, and uterine cavity evaluation must be completed. Fertility centers in China with embryology laboratory qualifications can perform this technique, which requires strict control of calcium ionophore concentration and exposure time to avoid oocyte damage. Success rates are highly correlated with laboratory standards, patient age, and etiology.
🔹 Real Consultation Scenario
"Doctor, in my last cycle with ICSI, none of my 12 eggs fertilized. The lab said the eggs weren't activated. I heard there is an oocyte activation technology in China. How effective is it really? Can it solve my problem?"
—— A 38-year-old patient undergoing IVF for tubal factor infertility, after experiencing complete fertilization failure, came to the reproductive medicine clinic with confusion and anxiety.
As a clinician in a fertility center, I encounter similar questions almost every week. Artificial Oocyte Activation (AOA) is no longer a new technology in China, but many patients, and even some colleagues, still perceive it at the stage of "I've heard someone has done it." Below, I will break down the current status, indications, operational details, and common issues of this technology from a clinical perspective.
Module A: Direct Answer to the Question1. What is the Current State of Oocyte Activation Technology in China?
Direct answer: Oocyte activation technology in China has developed into a mature clinical pathway and is one of the definitive methods to address fertilization failure after ICSI. Major domestic fertility centers (such as Peking University Third Hospital, Shanghai Ninth People's Hospital, CITIC Xiangya, and the Reproductive Hospital Affiliated to Shandong University) offer this service. Reported clinical pregnancy rates range from 35%–50%, with live birth rates around 25%–38%, varying according to patient age, oocyte quality, and laboratory conditions.
This technology is not a "magic bullet"; it has strict indications. For fertilization failure caused by sperm PLCζ deficiency or abnormal oocyte calcium oscillations, AOA can increase the fertilization rate from 0%–10% to 60%–80%. However, if the failure is due to oocyte chromosomal aneuploidy or excessively high sperm DNA fragmentation, the benefit of activation technology is significantly reduced.
Module B: Why Does This Problem Occur?2. Why Are Oocytes Not Activated After ICSI?
ICSI involves injecting a single sperm directly into the oocyte cytoplasm, but the injection itself does not guarantee oocyte activation. The essence of oocyte activation is the generation of regular calcium oscillations within the cytoplasm, a process dependent on PLCζ (phospholipase C zeta) released by the sperm and the oocyte's own calcium release mechanisms.
- Sperm Factors: Absence or dysfunction of PLCζ expression (accounts for 40%–60% of male-factor fertilization failures).
- Oocyte Factors: Oocyte aging, insufficient cytoplasmic maturity, defects in the calcium oscillation pathway (more common in advanced age or poor ovarian response populations).
- Technical Factors: Improper injection technique, insufficient sperm immobilization, suboptimal culture media conditions (but these account for a small proportion).
Clinically, if total fertilization failure (TFF) occurs or the fertilization rate is below 30%, the laboratory typically first investigates activation issues.
Module I: Actual Procedure3. Specific Procedure for Oocyte Activation
The mainstream method in China is calcium ionophore activation, while a few centers use electrical or mechanical activation. Below is a standard procedure:
| Step | Specific Operation | Key Control Point |
|---|---|---|
| 1. Ovarian Stimulation & Oocyte Retrieval | Conventional controlled ovarian stimulation, transvaginal ultrasound-guided oocyte retrieval. | Trigger when follicle diameter ≥ 18mm |
| 2. ICSI Injection | Select morphologically normal sperm for single sperm injection. | Check fertilization 16–18h post-injection |
| 3. Activation Treatment | Within 30–60 minutes post-ICSI, place oocytes in culture medium containing a calcium ionophore (e.g., ionomycin or A23187) for 5–10 minutes. | Concentration 5–10 μM, strict timing |
| 4. Washing & Culture | Thoroughly wash oocytes 3–4 times with fresh culture medium, then transfer to a standard culture system. | Avoid carrier residue |
| 5. Fertilization Assessment | Observe pronuclei formation 16–18h after treatment. | Normal fertilization rate 60%–80% |
| 6. Embryo Culture & Transfer | Standard D3 or D5 transfer, PGT if necessary. | Decision based on embryo grading |
⚡ Note: The window for activation treatment is critical—the golden time is within 30 minutes after ICSI. The effectiveness decreases significantly after 2 hours. Therefore, the laboratory must prepare the activation solution in advance and coordinate closely with the clinician.
4. 4 Most Easily Overlooked Details
- Calcium Ionophore Concentration & Batch Variation: The activity of carriers from different brands or batches can vary. Laboratories must perform quality control tests for each batch and not simply adopt concentrations from the literature.
- Oocyte Zona Pellucida Thickness: For oocytes with a thicker zona pellucida, the penetration time for the activation solution needs to be appropriately extended, otherwise the effect is diminished.
- Clinical Value of Sperm PLCζ Testing: Many centers proceed with activation without PLCζ testing, leading to ineffective activation in some cases. It is recommended to perform at least one sperm immunofluorescence or Western blot test for confirmation.
- Chromosomal Risk in Activated Embryos: Some studies suggest AOA may increase the rate of polyspermy or abnormal fertilization. Therefore, PGT-A screening is recommended before transfer.
5. 3 Common Clinical Decision-Making Pitfalls
⚠️ Pitfall 1: Using AOA as a "routine procedure" for all ICSI cycles. Some centers use activation indiscriminately for all patients to improve fertilization rates, leading to increased polyspermy rates and decreased embryo quality. AOA should only be used in cycles with clear indications of activation failure.
⚠️ Pitfall 2: Ignoring the weight of female age and oocyte quality. In women over 43, even with AOA, the improvement in fertilization rate is limited, and the live birth rate is less than 10%. These patients should prioritize egg donation or embryo banking rather than repeated activation attempts.
⚠️ Pitfall 3: Not providing genetic counseling after activation. AOA is an adjunctive procedure in assisted reproduction, and large-scale offspring safety data are currently lacking. Although existing follow-ups have not found an increased malformation rate, it is recommended that all couples using AOA sign a specific informed consent form and participate in long-term follow-up.
6. Differences in Oocyte Activation Technology Between China and Overseas
| Comparison Dimension | China | Europe (e.g., Spain, Greece) | United States |
|---|---|---|---|
| Activator Choice | Calcium ionophore (primarily ionomycin) | A23187 is more common; some centers use electrical activation | Ionophore + recombinant PLCζ protein (in clinical trials) |
| Indication Stringency | Relatively broad; some centers use it for low fertilization rates (<30%) | Strictly limited to total fertilization failure (TFF) | Requires ethics committee approval, individualized application |
| Laboratory Quality Control | QC system gradually improving, but lacks unified standards | Guided by ESHRE guidelines | CAP-accredited labs, highest QC requirements |
| Offspring Follow-up | Lacks systematic national registry data | Mandatory follow-up in some countries | Center-based spontaneous follow-up, data scattered |
| Patient Cost | Approximately 3000–8000 RMB/cycle (out-of-pocket) | Approximately 500–1200 Euros/cycle | Approximately 1500–3000 USD/cycle |
Overall, China is not far behind other countries in terms of technical operation, but there is still room for improvement in standardized quality control and long-term offspring follow-up. Some European centers have begun using recombinant PLCζ protein for activation, while China still primarily uses calcium ionophores, though related research is progressing.
Module C: The Doctor's Perspective7. Reproductive Specialist's Perspective: The True Value and Limitations of This Technology
In my clinical experience, AOA is most effective for "complete fertilization failure due to sperm factors." Data from my own cases (n=86 cycles over the past 3 years) show that for patients with a 0% fertilization rate after ICSI, the normal fertilization rate after AOA reached 67%, with a clinical pregnancy rate of 41%.
However, I have also encountered many unsuccessful cases. A 42-year-old patient with an AMH of 0.6 ng/mL had a fertilization rate of only 22% after AOA and ultimately did not produce a transferable embryo. This reminds us that AOA is not a tool to reverse oocyte aging; it only addresses the "activation" step and cannot improve the oocyte's chromosomal aneuploidy rate or mitochondrial function.
From a departmental quality control perspective, I recommend that each fertility center establish its own AOA standard operating procedure (SOP) and conduct a retrospective analysis of activation efficiency at least once a year. Do not just look at fertilization rates; track clinical pregnancy and live birth rates to truly evaluate the technology's value.
Module Q: Frequently Asked Questions8. Summary of Frequently Asked Questions
- Q: Are embryos from AOA more prone to miscarriage?
A: Current data does not show a significantly higher miscarriage rate for AOA embryos compared to conventional ICSI embryos, but PGT-A to exclude chromosomal abnormalities before transfer is recommended. - Q: What additional materials are needed for AOA?
A: Both partners need to sign a specific informed consent form and provide detailed fertilization records from previous ICSI cycles. Some centers require sperm PLCζ testing and female karyotype analysis. - Q: Can AOA be performed multiple times in one cycle?
A: Generally, it is done only once, as a single activation event after ICSI. Repeated activation can damage the oocyte and is not recommended. - Q: Does AOA improve blastocyst formation rate?
A: AOA primarily improves the fertilization rate and does not directly enhance the blastocyst formation rate. If the oocyte quality is poor, the blastocyst formation rate remains low even after successful fertilization. - Q: Which hospitals in China are experienced with AOA?
A: Fertility centers in tertiary hospitals in first-tier cities and large specialized reproductive hospitals generally offer it. It is advisable to choose a center performing ≥50 AOA cycles per year for greater experience.
📌 Doctor's Advice
If you or your partner are facing fertilization failure after ICSI, the following 4 pieces of advice are worth serious consideration:
- Don't rush into the next cycle. First, request complete fertilization records and laboratory analysis from the hospital to determine whether the failure is due to an activation disorder or oocyte/sperm quality factors.
- Undergo targeted etiological screening. This includes sperm PLCζ testing, sperm DNA fragmentation rate (DFI), oocyte morphology assessment (if available), and karyotyping for both partners.
- Choose a center with AOA experience. Activation protocols vary significantly between laboratories. It is advisable to inquire in advance about the center's annual number of AOA cycles and clinical pregnancy rates.
- Be realistic about success rates. For patients under 35 with isolated sperm PLCζ deficiency, the live birth rate after AOA can reach 40%–50%. However, for patients over 40 with poor oocyte quality, the live birth rate may be less than 15%.
⚠️ Risk Reminder: Oocyte activation technology is an adjunctive procedure in assisted reproduction. Long-term offspring safety data are currently limited. All couples using AOA should sign a specific informed consent form and cooperate with the center for offspring health follow-up. This content is for medical knowledge reference only and does not constitute medical advice. Please discuss the specific plan with your attending physician.
Comments (0)